GPR107 (G protein-coupled receptor 107) is an orphan receptor involved in intracellular trafficking, toxin entry, and cardiovascular regulation. Antibodies targeting GPR107 are primarily polyclonal (rabbit) and are used in:
Western blot (WB): Detection of denatured protein (60–67 kDa) .
Immunofluorescence (IF)/ICC: Localization studies in HEK-293 cells and tissue sections .
Immunohistochemistry (IHC): Paraffin-embedded or frozen tissue analysis .
Live-cell imaging: Tracking GPR107 localization in real-time.
Co-localization studies: Identifying interactions with Golgi/TGN markers .
Flow cytometry: Quantifying GPR107 expression on cell surfaces.
GPR107 is critical for retrograde transport from the Golgi to the endoplasmic reticulum (ER). It is required for the entry of Pseudomonas aeruginosa exotoxin A (PE) and Campylobacter jejuni CDT toxins, acting as a host factor in toxin trafficking .
Mechanism: Cleaved by furin, GPR107 facilitates toxin retrograde transport, potentially via G-protein interactions .
GPR107 is proposed as a receptor for neuronostatin, a peptide involved in central cardiovascular control. This interaction may modulate blood pressure and heart rate .
Custom Synthesis: Contact suppliers like Proteintech, Boster Bio, or R&D Systems to inquire about conjugation services.
In-House Conjugation: Use FITC labeling kits (e.g., Thermo Fisher Scientific) with validated GPR107 antibodies (e.g., DF4939 , 25076-1-AP ).
Validation: Test conjugated antibodies in IF/ICC to confirm specificity and fluorescence efficiency.
Lack of Commercial FITC-Conjugated Products: No vendors explicitly list FITC-labeled GPR107 antibodies, necessitating custom synthesis.
Unexplored Applications: FITC conjugation could enable time-lapse studies of GPR107 dynamics in toxin trafficking or cardiovascular signaling.